1932-8737/asset/CLC_left.gif?v=1&s=bef78ae8a6fe49b573c871234f8b53b4936d2259)
Case Report
You have free access to this content
Cardiac Amyloidosis Treated with an Implantable Cardioverter Defibrillator and Subcutaneous Array Lead System: Report of a Case and Literature Review
Article first published online: 19 MAY 2009
DOI: 10.1002/clc.20389
Copyright © 2009 Wiley Periodicals, Inc.
1932-8737/asset/cover.gif?v=1&s=aa8daa91991e0fc34c181e4dad93e63f1b1cc6bd "Clinical Cardiology")
Additional Information
How to Cite
Dhoble, A., Khasnis, A., Olomu, A. and Thakur, R. (2009), Cardiac Amyloidosis Treated with an Implantable Cardioverter Defibrillator and Subcutaneous Array Lead System: Report of a Case and Literature Review. Clin Cardiol, 32: E63–E65. doi: 10.1002/clc.20389
Publication History
- Issue published online: 17 AUG 2009
- Article first published online: 19 MAY 2009
- Manuscript Accepted: 9 DEC 2007
- Manuscript Received: 22 SEP 2007
References
- 1, , . Amyloidosis and the heart: A comprehensive review. Arch Intern Med 2006; 166: 1805–1813.
- 2, , . Cardiac arrhythmias in systemic amyloidosis: Correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984; 3: 107–113.
- 3, . Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 1981; 60: 429–448.
- 4, , , , . Features and prognosis of exertional syncope in light chain associated AL cardiac amyloidosis. Am J Cardiol 1997; 80: 1242–1245.
- 5, , , . Single incision and single element Array electrode to lower the defibrillation threshold. Ann Thorac Surg 1997; 64: 1177–1179.
- 6, . How to manage patients with high defibrillation threshold. J Heart Rhythm Soc 2006; 3: 492–495.
- 7, , , . Comparison of the efficacy of a subcutaneous array electrode with a subcutaneous patch electrode, a prospective randomized study. Int J Cardiol 2001; 78: 247–256.
- 8, , . A subcutaneous lead array for implantable cardioverter defibrillators. PACE 1993; 16: 1429–1432.
- 9, , , . The subcutaneous array: A new lead adjunct for the transvenous ICD to lower defibrillation threshold. PACE 1995; 18: 1540–1548.
- 10, , , et al. Non-pharmacological therapy for malignant ventricular arrhythmias: Implantable defibrillator trials. Prog Cardiovasc Dis 1996; 38: 429–444.
- 11, , , et al. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol 21(12): 2596–2605.Direct Link:
- 12, , , , . Implantable cardioverter defibrillator lead technology: Improved performance and lower defibrillation thresholds. Pacing Clin Electrophysiol 1995; 18: 548–559.Direct Link: